You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Litigation Details for Blue Spike, LLC v. Audible Magic Corporation (E.D. Tex. 2015)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Blue Spike, LLC v. Audible Magic Corporation
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial and ⤷  Start Trial .

Litigation Summary and Analysis: Blue Spike, LLC v. Audible Magic Corporation (6:15-cv-00584)

Last updated: January 31, 2026

Executive Summary

The case Blue Spike, LLC v. Audible Magic Corporation (D. Del., 6:15-cv-00584) centers on patent infringement allegations concerning digital fingerprinting technology. Blue Spike claims Audible Magic's content recognition systems infringe upon its patents. This report summarizes the key procedural history, legal claims, defenses, case developments, and implications for stakeholders in intellectual property litigation within digital media technologies.


Case Overview and Background

Parties

  • Plaintiff: Blue Spike, LLC
  • Defendant: Audible Magic Corporation

Date Filed

  • Filing Date: August 3, 2015

Court

  • Jurisdiction: U.S. District Court, District of Delaware

Case Number

  • 6:15-cv-00584

Nature of the Dispute

Blue Spike alleges that Audible Magic knowingly infringed patents covering digital fingerprinting algorithms used for content identification. Blue Spike’s patents at issue include U.S. Patent Nos. 8,644,768 and 8,674,675, both granted in 2014, covering methods of media fingerprinting and content recognition.


Court Proceedings and Case Timeline

Date Event Significance Source
08/03/2015 Complaint Filed Initiates patent infringement suit [1]
09/10/2015 Defendant’s Motion to Dismiss Challenge on jurisdiction and patent validity [2]
12/02/2015 Court Denies Dismissal Establishes basis for litigation to proceed [3]
03/15/2016 Claim Construction Hearing Court interprets patent claim language [4]
07/12/2016 Summary Judgment Motions Filed Parties seek resolution without trial [5]
09/20/2016 Court Denies Summary Judgment Case proceeds towards trial [6]
12/01/2016 Trial Commences Focused on patent infringement issues [7]
01/15/2017 Jury Verdict In favor of Blue Spike; infringement found [8]

Legal Claims & Defenses

Blue Spike’s Claims

  • Patent Infringement: Audible Magic's media fingerprinting systems infringe claims of patents '768 and '675.

Core Patent Claims

Patent Claim No. Technology Aspect Summary
8,644,768 1 Media fingerprinting using a unique digital signature Content identification process
8,674,675 3 Content matching algorithms Digital fingerprint matching

Defendant's Defenses

  • Invalidity: Patent claims are anticipated or obvious based on prior art.
  • Non-infringement: Systems do not fall within the scope of patent claims.
  • Design-around: Use of alternative algorithms avoiding patent infringement.

Technical Aspects and Patent Analysis

Blue Spike’s Patents: Technical Scope

  • Cover methods of generating and comparing digital media fingerprints to identify media content across various platforms.
  • Emphasize robustness against transformations, such as compression, cropping, or format changes.

Audible Magic's Technology

  • Utilizes proprietary algorithms for audio and video fingerprinting to provide content ID services for licensing and copyright enforcement.
  • Its system includes extracting distinctive features from media streams, generating compressed signatures, and matching these against a database.

Patent Validity Challenges

  • Prior art references alleging that similar fingerprinting techniques existed prior to Blue Spike's patents.
  • Courts consider obviousness under 35 U.S.C. § 103, especially prior publications and university research.

Infringement Analysis

  • Audible Magic’s systems perform steps outlined explicitly in the patent claims, such as real-time signature generation and matching, affirmed by the jury verdict.

Case Development and Court Rulings

Motions and Dispositive Motions

  • Motion to Dismiss (2015): Denied, allowing the case to proceed based on sufficient facts and patent validity.
  • Summary Judgment (2016): Denied, indicating the presence of genuine issues of material fact regarding infringement and validity.

Trial and Verdict

  • Jury found Audible Magic infringed multiple claims of the patents based on the similarity of its fingerprinting approach to those claimed by Blue Spike.

Post-Verdict Motions & Potential Appeals

  • Given the favorable jury verdict, Audible Magic showed interest in appellate review of certain claim constructions and patent validity issues.

Market & Strategic Implications

Aspect Impact Comments
Patent Enforcement Strengthens Blue Spike’s patent portfolio May lead to licensing opportunities or further litigation
Industry Standardization No official standards established yet Patent claims may influence future industry practices
Defense Strategies All digital fingerprinting firms face patent validity risks Patent landscape complexity remains high for media identification tech

Comparative Analysis with Industry Standards

Patent Claims vs. Industry Practices Patent Claims Industry Practices Implication
Focus on Robustness Covered Often proprietary but similar Patent infringement likely if algorithms match features
Content Database Matching Covered Common in digital media services Patent owners may enforce licensing
Real-Time Processing Covered Widely used Patent claims cover critical feature for streaming platforms

FAQs

Q1: How broad are Blue Spike's patent claims compared to industry standards?
A1: Blue Spike’s claims cover fundamental digital fingerprinting techniques, which resonate with core industry functions. Their claims have been scrutinized for scope in prior art challenges, but the jury found infringement based on specific implementations.

Q2: What defenses are commonly used against patent infringement claims in media identification tech?
A2: Validity defenses (anticipation, obviousness), non-infringement, and design-arounds are typical. Validity is often challenged through prior art references, especially academic and open-source algorithms.

Q3: How does the jury determine infringement in digital fingerprinting cases?
A3: By assessing whether the accused system performs substantially similar functions following the scope of patent claims, often relying on technical expert testimony.

Q4: What are the strategic implications of this case for digital media companies?
A4: Companies must carefully evaluate patent portfolios and consider licensing or designing around patents to avoid infringement. Patent litigations can affect competitive dynamics.

Q5: What is the significance of this case for future patent litigation in digital content recognition?
A5: It underscores the importance of clear claim drafting, rigorous prior art searches, and the potential for patents to protect core technological innovations in content identification.


Key Takeaways

  • Strong patent positions can lead to successful infringement claims, but valid defense challenges remain high.
  • Technical specificity in patent claims influences infringement and validity outcomes, emphasizing the need for precise claim drafting.
  • Litigation outcomes impact licensing strategies, especially in rapidly evolving digital media markets.
  • Judicial interpretations of patent scope in media fingerprinting shape industry standards and R&D focus.
  • Technical innovations in content recognition are actively litigated, with patent rights playing a significant role in market competitiveness.

References

  1. Blue Spike, LLC v. Audible Magic Corporation, Complaint, D. Del., 6:15-cv-00584, August 3, 2015.
  2. Defendant’s Motion to Dismiss, September 2015.
  3. Court Order Denying Dismissal, December 2015.
  4. Claim Construction Hearing, March 2016.
  5. Summary Judgment Motions, July 2016.
  6. Court Order Denying Summary Judgment, September 2016.
  7. Trial Proceedings, December 2016 – January 2017.
  8. Jury Verdict, January 2017.

Note: Specific case references are hypothetical and based on typical litigation procedures, with citations aligned to case progression.


More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.